Comparison of Self-assessment vs. Assessment by Others of Critically Ill Patients (ASTON)

October 5, 2020 updated by: Technical University of Munich

Agreement in Relatives' Assessment in Standardized Questionnaires of Patients Who Have Been Admitted to Intensive Care Compared to Patients Who Have Not Been Admitted to Intensive Care (ASTON Study)

We will test the results of standardized questionnaires for patients admitted to intensive care assessed by relatives/caregivers compared to the patient itself. Furthermore we will compare results with patients not admitted to intensive care.

Study Overview

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 13353
        • Charité - Universitätsmedizin Berlin
    • Bavaria
      • Munich, Bavaria, Germany, 81675
        • Klinikum rechts der Isar, School of Medicine, Technical University of Munich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Surgical patients with a high risk to be admitted to intensive care

Description

Inclusion Criteria:

  • patient with a postoperative risk to be admitted to intensive care
  • signed informed consent

Exclusion Criteria:

  • patient who is not able to fill out the questionnaires alone and independent
  • patient without relatives or a caregiver who could answer the assessment after surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Intensive Care Patients
Postoperative patients who have been admitted to intensive care
WHO Disability Score
Health related quality of life measured with European Quality of Life 5 Dimensions 5 Level
The Lawton Instrumental Activities of Daily Living
Barthel Score of the patient
Short Form Health 36
Montreal Cognitive Assessment
Non-Intensive Care Patients
Postoperative patients who have not been admitted to intensive care but to the normal ward
WHO Disability Score
Health related quality of life measured with European Quality of Life 5 Dimensions 5 Level
The Lawton Instrumental Activities of Daily Living
Barthel Score of the patient
Short Form Health 36
Montreal Cognitive Assessment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement in assessment of ICU patients
Time Frame: 2 weeks before hospital admission
Comparison of results of self-assessment versus assessment by others of standardized questionnaires of postoperative patients admitted to intensive care
2 weeks before hospital admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement in assessment of ICU vs. non-ICU patients
Time Frame: 2 weeks before hospital admission
Comparison of results of assessment of questionnaires of ICU patients vs. non-ICU patients
2 weeks before hospital admission
Agreement in assessment of non-ICU patients
Time Frame: 2 weeks before hospital admission
Comparison of results of self-assessment versus assessment by others of standardized questionnaires of postoperative patients not admitted to intensive care but to the normal ward
2 weeks before hospital admission
Multivariate testing using the closeness of the relationship
Time Frame: 2 weeks before hospital admission
It will be tested if the closeness of relationship patient - relative/caregiver changes the agreement, i.e. if the agreement is dependent or independent of the closeness of the relationship
2 weeks before hospital admission

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Definition of criteria which define an appropriate close relationship to receive a reliable test result
Time Frame: 2 weeks before hospital admission
Test which closeness of relationship is sufficient to provide adequate test results compared with the patient's answers
2 weeks before hospital admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Steffen Weber-Carstens, MD, Charite University, Berlin, Germany

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2019

Primary Completion (Actual)

August 15, 2020

Study Completion (Actual)

August 15, 2020

Study Registration Dates

First Submitted

December 17, 2018

First Submitted That Met QC Criteria

December 19, 2018

First Posted (Actual)

December 24, 2018

Study Record Updates

Last Update Posted (Actual)

October 6, 2020

Last Update Submitted That Met QC Criteria

October 5, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Anonymized data will be made available to other researchers on reasonable request. A data share agreement will have to be signed by both parties.

Examples of reasonable requests are:

  • a metaanalysis in the field
  • a research collaboration
  • rerun the analysis

Data will only be provided for the purpose requested and may not be used otherwise without authorization/agreement.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on WHODAS 2.0

Subscribe